IFP Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.5K | Sell |
|
|||||
|
2025
Q1 | $62.6K | Sell |
|
|||||
|
2024
Q4 | $56.7K | Buy |
|
|||||
|
2024
Q3 | $53.6K | Buy |
|
|||||
|
2024
Q2 | $11.9K | Sell |
|
|||||
|
2024
Q1 | $70.2K | Buy |
|
|||||
|
2023
Q4 | $87.2K | Buy |
|
|||||
|
2023
Q3 | $80.3K | Buy |
|
|||||
|
2023
Q2 | $86K | Sell |
|
|||||
|
2023
Q1 | $45.9K | Sell |
|
|||||
|
2022
Q4 | $80K | Sell |
|
|||||
|
2022
Q3 | $109K | Buy |
|
|||||
|
2022
Q2 | $93K | Hold |
|
|||||
|
2022
Q1 | $93K | Buy |
|
|||||
|
2021
Q4 | $73K | Buy |
|
|||||
|
2021
Q3 | $77K | Buy |
|
|||||
|
2021
Q2 | $60K | Buy |
|
|||||
|
2021
Q1 | $5K | Buy |
|
|||||
|
2020
Q4 | $1K | Sell |
|
|||||
|
2020
Q3 | $1K | Buy |
|
|||||
|
2020
Q2 | $1K | Hold |
|
|||||
|
2020
Q1 | $1K | Hold |
|
|||||
|
2019
Q4 | $1K | Hold |
|
|||||
|
2019
Q3 | $1K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $14K | Sell |
|
|||||
|
2018
Q3 | $49K | Buy |
|
|||||
|
2018
Q2 | $45K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $13K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $26K | Buy |
|